McDonnell T, Kalra P, Vuilleumier N, Cockwell P, Wheeler D, Fraser S
Am J Nephrol. 2024; 56(1):1-12.
PMID: 39369692
PMC: 11812588.
DOI: 10.1159/000541770.
Xu W, Hou L
Clin Exp Nephrol. 2024; 28(12):1241-1253.
PMID: 39168882
DOI: 10.1007/s10157-024-02545-z.
Yang Y, Chen J, Zhang S, Zhu S, Zhu H
Med Sci Monit. 2024; 30:e942324.
PMID: 38494662
PMC: 10958980.
DOI: 10.12659/MSM.942324.
Reznichenko A, Nair V, Eddy S, Fermin D, Tomilo M, Slidel T
Kidney Int. 2024; 105(6):1263-1278.
PMID: 38286178
PMC: 11751912.
DOI: 10.1016/j.kint.2024.01.012.
Levin A, Borkum M
Clin Kidney J. 2023; 16(3):437-441.
PMID: 36865013
PMC: 9972821.
DOI: 10.1093/ckj/sfac226.
Selecting the right therapeutic target for kidney disease.
Buvall L, Menzies R, Williams J, Woollard K, Kumar C, Granqvist A
Front Pharmacol. 2022; 13:971065.
PMID: 36408217
PMC: 9666364.
DOI: 10.3389/fphar.2022.971065.
Association of Contrast-Enhanced Ultrasound-Derived Kidney Cortical Microvascular Perfusion with Kidney Function.
Srivastava A, Sridharan A, Walmer R, Kasoji S, Burke L, Dayton P
Kidney360. 2022; 3(4):647-656.
PMID: 35721623
PMC: 9136891.
DOI: 10.34067/KID.0005452021.
Radiomics-Based Image Phenotyping of Kidney Apparent Diffusion Coefficient Maps: Preliminary Feasibility & Efficacy.
Li L, Leidner A, Wilt E, Mikheev A, Rusinek H, Sprague S
J Clin Med. 2022; 11(7).
PMID: 35407587
PMC: 8999417.
DOI: 10.3390/jcm11071972.
The Associations of Plasma Biomarkers of Inflammation With Histopathologic Lesions, Kidney Disease Progression, and Mortality-The Boston Kidney Biopsy Cohort Study.
Srivastava A, Schmidt I, Palsson R, Weins A, Bonventre J, Sabbisetti V
Kidney Int Rep. 2021; 6(3):685-694.
PMID: 33732983
PMC: 7938082.
DOI: 10.1016/j.ekir.2020.12.025.
Rationale and design of the Kidney Precision Medicine Project.
de Boer I, Alpers C, Azeloglu E, Balis U, Barasch J, Barisoni L
Kidney Int. 2021; 99(3):498-510.
PMID: 33637194
PMC: 8330551.
DOI: 10.1016/j.kint.2020.08.039.
The Role of Prognostic and Predictive Biomarkers for Assessing Cardiovascular Risk in Chronic Kidney Disease Patients.
Provenzano M, Andreucci M, De Nicola L, Garofalo C, Battaglia Y, Borrelli S
Biomed Res Int. 2020; 2020:2314128.
PMID: 33102575
PMC: 7568793.
DOI: 10.1155/2020/2314128.
Contribution of Predictive and Prognostic Biomarkers to Clinical Research on Chronic Kidney Disease.
Provenzano M, Rotundo S, Chiodini P, Gagliardi I, Michael A, Angotti E
Int J Mol Sci. 2020; 21(16).
PMID: 32823966
PMC: 7461617.
DOI: 10.3390/ijms21165846.
Longitudinal Changes in Kidney Function Estimated from Cystatin C and Its Association with Mortality in Elderly Women.
Malmgren L, McGuigan F, Christensson A, Akesson K
Nephron. 2020; 144(6):290-298.
PMID: 32392561
PMC: 7384338.
DOI: 10.1159/000507256.
New Intravenous Calcimimetic Agents: New Options, New Problems. An Example on How Clinical, Economical and Ethical Considerations Affect Choice of Treatment.
Piccoli G, Trabace T, Chatrenet A, Carranza de La Torre C, Gendrot L, Nielsen L
Int J Environ Res Public Health. 2020; 17(4).
PMID: 32075103
PMC: 7068561.
DOI: 10.3390/ijerph17041238.
Identification and external validation of IgA nephropathy patients benefiting from immunosuppression therapy.
Chen T, Xia E, Chen T, Zeng C, Liang S, Xu F
EBioMedicine. 2020; 52:102657.
PMID: 32062356
PMC: 7016365.
DOI: 10.1016/j.ebiom.2020.102657.
CKD: A Call for an Age-Adapted Definition.
Delanaye P, Jager K, Bokenkamp A, Christensson A, Dubourg L, Eriksen B
J Am Soc Nephrol. 2019; 30(10):1785-1805.
PMID: 31506289
PMC: 6779354.
DOI: 10.1681/ASN.2019030238.
The Surprise Question and Self-Rated Health Are Useful Screens for Frailty and Disability in Older Adults with Chronic Kidney Disease.
Baddour N, Robinson-Cohen C, Lipworth L, Bian A, Stewart T, Jhamb M
J Palliat Med. 2019; 22(12):1522-1529.
PMID: 31259659
PMC: 6882450.
DOI: 10.1089/jpm.2019.0054.
Journal clubs in the digital age: Twitter for continuing professional development.
McGinnigle E, Francis R, Warriner D, McAloon C
Future Healthc J. 2019; 4(3):160-166.
PMID: 31098464
PMC: 6502588.
DOI: 10.7861/futurehosp.4-3-160.
The Primary-Secondary Care Partnership to Improve Outcomes in Chronic Kidney Disease (PSP-CKD) Study: A Cluster Randomized Trial in Primary Care.
Major R, Brown C, Shepherd D, Rogers S, Pickering W, Warwick G
J Am Soc Nephrol. 2019; 30(7):1261-1270.
PMID: 31097609
PMC: 6622412.
DOI: 10.1681/ASN.2018101042.
Mortality Risk in IgA Nephropathy.
Glassock R
J Am Soc Nephrol. 2019; 30(5):720-722.
PMID: 31040186
PMC: 6493985.
DOI: 10.1681/ASN.2018121255.
